Clovis Oncology Inc
Change company Symbol lookup
Select an option...
CLVS Clovis Oncology Inc
AMTD TD Ameritrade Holding Corp
T AT&T Inc
PFE Pfizer Inc
ORIT Oritani Financial Corp
OMI Owens & Minor Inc
MAT Mattel Inc
GNSS Genasys Inc
AMNF Armanino Foods Of Distinction Inc
FCX Freeport-McMoRan Inc
Go

Health Care : Biotechnology | Small Cap BlendCompany profile

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and other international markets. The Company’s product Rubraca (rucaparib), an oral small molecule inhibitor of poly adenosine diphosphate (ADP)-ribose polymerase (PARP), is marketed in the United States for two indications specific to recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. The Company also provides Lucitanib, which is an investigational, oral, potent inhibitor of the tyrosine kinase activity of vascular endothelial growth factor receptors one through three (VEGFR1-3), platelet-derived growth factor receptors alpha and beta, and fibroblast growth factor receptors one through three (FGFR1-3).

Closing Price
$7.01
Day's Change
-0.78 (-10.01%)
Bid
--
Ask
--
B/A Size
--
Day's High
7.79
Day's Low
6.90
Volume
(Light)
Volume:
7,459,308

10-day average volume:
15,149,213
7,459,308
  • Prev Close
    7.79
  • Today's Open
    7.54
  • Day's Range
    6.90-7.79
  • Avg Vol (10-day)
    15.1M
  • Last (time)
    4:00p ET 11/20/19
  • Last (size)
    188
  • 52-Wk Range
    2.93 - 32.05
    LowHigh
  • (02/28/19 - 10/28/19)
    139.25%
  • 99.1%
  • Market Cap
    384.3M
  • Shares Outstanding
    54.8M
  • -7.51
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 2.2
  • 100.94
  • (% of float 10/31/19)
    41.40

Latest News

November 19, 2019
7:42 am ET
MarketWatch
7:42 am ET
MarketWatch
November 13, 2019
4:00 am ET
BusinessWire
November 07, 2019
8:00 am ET
BusinessWire
October 29, 2019
11:00 am ET
PR Newswire
October 22, 2019
8:30 am ET
BusinessWire
8:30 am ET
PR Newswire
October 11, 2019
9:19 am ET
BusinessWire
September 29, 2019
2:30 am ET
BusinessWire
September 24, 2019
8:49 am ET
MarketWatch
8:49 am ET
MarketWatch
September 23, 2019
4:00 am ET
BusinessWire
September 12, 2019
4:00 am ET
BusinessWire
August 28, 2019
8:05 am ET
BusinessWire
August 02, 2019
8:27 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.